'Gimme five': future challenges in multiple sclerosis. ECTRIMS Lecture 2009.
Multiple Sclerosis 2010 January; 16(1): 3-14
This article is based on the ECTRIMS lecture given at the 25( th) ECTRIMS meeting which was held in Dusseldorf, Germany, from 9 to 12 September 2009. Five challenges have been identified: (1) safeguarding the principles of medical ethics; (2) optimizing the risk/benefit ratio; (3) bridging the gap between multiple sclerosis and experimental autoimmune encephalitis; (4) promoting neuroprotection and repair; and (5) tailoring multiple sclerosis therapy to the individual patient. Each of these challenges will be discussed and placed in the context of current research into the pathogenesis and treatment of multiple sclerosis.
Permanent LinkFind Full Text at Georgetown University Library
Full Text from Publisher
Showing items related by title, author, creator and subject.
The Future of Multiple Sclerosis Therapies: Redesigning Multiple Sclerosis Clinical Trials in a New Therapeutic Era McFarland, Henry F.; Reingold, S.C. (2005-12)
Ethical Aspects of Unproved Therapies in Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Other Neurologic Diseases van den Noort, Stanley (1984-03)
Ethical Aspects of Unproved Therapies in Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Other Neurologic Diseases Van den Noort, Stanley (1984-03)